Nathan Scott Hall, DO, MBA, MS¹, Alan S. Gamis, MD, MPH² and Matt Hall, PhD^3*

¹Childrens Mercy Hospital, Kansas City, MO
²Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
³Children's Hospital Association, Overland Park, KS

Samip Master, MD¹, Zhenzhen Shi^2*, Srinivas S. Devarakonda, MD³, Reinhold Munker, MD⁴ and Runhua Shi, MD PhD MPH^3*

¹Feist-Weiller Cancer Center, LSU Medical Center, Shreveport, LA
²Tulane University, New Orleans, LA
³Department of Hematology/Oncology, LSU Health Sciences Center, Shreveport, LA
⁴Department of Hematology/Oncology, LSUHSC-Shreveport, Shreveport, LA

Christopher Flowers, MD¹, Chadi Nabhan, MD², Neil E. Kay, MD³, Anthony Mato, MD^4*, Nicole Lamanna, MD⁵, David L. Grinblatt, MD⁶, Thomas J. Kipps, M.D., PhD.⁷, Mark Kozloff, MD^8*, Kristen Sullivan^9*, E. Dawn Flick, RPh, MPH, ScD^10*, Pavel Kiselev, PhD^11*, Shriya Bhushan, PharmD^11*, Arlene S. Swern, PhD^11* and Jeff P. Sharman, MD¹²

¹Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Columbia University Medical Center, New York, NY
⁶NorthShore University HealthSystem, Evanston, IL
⁷Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁸Ingalls Cancer Research Center, Harvey, IL
⁹Celgene Corporation, Overland Park, KS
¹⁰Celgene Corporation, South San Francisco, CA
¹¹Celgene Corporation, Summit, NJ
¹²Willamette Valley Cancer Institute, Springfield, OR

Amer M. Zeidan, MBBS, MHS¹, Jessica B. Long, PhD^2*, Jane Hall^2*, Rong Wang, PhD^2*, Scott F Huntington, MD MPH¹, Gregory Abel, MD, MPH³, Thomas Prebet, MD⁴, Nikolai A. Podoltsev, MD, PhD¹, Cary P. Gross, MD^1*, Steven D. Gore, MD⁵, Xiaomei Ma, PhD^2* and Amy J. Davidoff, PhD^2*

¹Yale University School of Medicine, New Haven, CT
²Yale University School of Public Health, New Haven, CT
³Dana-Farber Cancer Inst., Boston, MA
⁴Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
⁵Yale Cancer Center, New Haven, CT

Amy E. DeZern, MD, MHS¹, Gary Binder^2*, Albert Fliss, PhD^2*, X. Henry Hu, MD, PhD^2*, Syed Rizvi, MD², Frank A. Corvino^3*, Steven R. Arikian, MD^3*, Andy Surinach^3*, Jianyi Lee^3* and B. Douglas Smith, MD¹

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
²Celgene Corporation, Summit, NJ
³Genesis Research, Hoboken, NJ

Sean A. Fletcher^1*, Angel M. Cronin, MS^1*, Amer M. Zeidan, MBBS, MHS², Oreofe O. Odejide, MD¹, Steven D. Gore, MD², Amy J. Davidoff, PhD^2*, David P. Steensma, MD¹ and Gregory A. Abel, MD, MPH¹

¹Dana-Farber Cancer Institute, Boston, MA
²Yale Cancer Center, New Haven, CT

Dianne Pulte, MD, Lina Jansen, PhD^*, Felipe Castro, PhD^* and Hermann Brenner, MD, MPH^*

German Cancer Research Center, Heidelberg, Germany

Samantha J Mayo, RN, PhD^1*, Hans A. Messner, M.D./Ph.D², Sean B. Rourke, PhD^3*, Doris Howell, RN PhD^1,4*, J. Charles Victor^5*, John Kuruvilla, MD⁶, Jeffrey H. Lipton, MD, PhD⁷, Vikas Gupta, MD, MRCP, FRCPath², Dennis Dong Hwan Kim, MD, PhD^2*, Laura McGillis, BScN, MN, RN(EC), CONc^4*, Jieun Uhm, MD², Fotios V. Michelis, MD, PhD⁸, Naheed Alam, MBBS, MD², Anna Lambie, RN NP^2*, Dawn Breen, RN^2*, David Loach, MD^2*, Christine Piescic, RN^2* and Kelly Metcalfe, RN PhD^1,9*

¹Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
²Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
³St. Michael's Hospital, Toronto, ON, Canada
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
⁶Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁷Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁹Women’s College Research Institute, Toronto, ON, Canada

Oreofe O. Odejide, MD¹, Angel M. Cronin^1*, Nolan B. Condron^1*, Sean A. Fletcher^1*, Craig Earle, MD^2* and Gregory A. Abel, MD, MPH¹

¹Dana-Farber Cancer Institute, Boston, MA
²Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

Sarah K. Dobrozsi, MD, MS¹ and Julie A. Panepinto, MD, MSPH²

¹Pediatrics, Medical College of Wisconsin, Milwaukee, WI
²The Medical College of Wisconsin/Children's Research Institute of the Children's Hospital of Wisconsin, Milwaukee, WI

Paolo Milani, MD^1,2*, Morie A. Gertz, MD², Giampaolo Merlini, MD¹, Giovanni Palladini, MD, PhD³, Martha Q. Lacy, MD², Francis K. Baudi^2*, Shaji K. Kumar, MD², Suzanne R. Hayman, MD², Nelson Leung, MD⁴, David Dingli, MD, PhD², John A. Lust, MD, PhD², Yi Lin, MD, PhD², Prashant Kapoor, MD², Ronald S. Go, MD², Steven R. Zeldenrust, MD, PhD², Yi L. Hwa, NP^2*, Robert A. Kyle, MD², S. Vincent Rajkumar² and Angela Dispenzieri, MD²

¹Amyloidosis Research and Treatment Center, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Division of Hematology, Mayo Clinic, Rochester, MN
³Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Department of Molecular Medicine, Pavia, Italy
⁴Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Vasily Shuvaev, MD¹, Kudrat Abdulkadyrov, MD, PhD^1*, Anna Turkina, Prof., MD², Irina Martynkevich, MD, PhD^1*, Ekaterina Chelysheva, MD, PhD^2*, Mikhail Fominykh, MD¹ and Valentin Martchenko^3*

¹Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia
²Federal State Budgetary Institution Hematology Research center of Healthcare Ministry of Russian Federation, Moscow, Russia
³Russian Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russia

Steven R Arikian^1*, Gary Binder^2*, Craig Gibson^2*, X Henry Hu^2*, Yasir Nagarwala², Mohamad A. Hussein², Frank A. Corvino^1*, Jianyi Lee^1*, Andy Surinach^1*, Satyin Kaura^2* and Saad Usmani^3*

¹Genesis Research, Hoboken, NJ
²Celgene Corporation, Summit, NJ
³Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC

Rong Wang, PhD^1,2,3*, Amer M. Zeidan, MBBS, MHS^2,3,4, Pamela R Soulos, MPH^2,4*, James B. Yu, MD^2,3,4*, Amy J. Davidoff, PhD^1,2,3*, Steven D. Gore, MD^2,3,4*, Cary P. Gross, MD^2,3,4* and Xiaomei Ma, PhD^1,2,3*

¹Yale University School of Public Health, New Haven, CT
²Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
³Yale Cancer Center, New Haven, CT
⁴Yale University School of Medicine, New Haven, CT

Vernon F Schabert III, Ph.D.^1*, Essy Mozaffari, PharmD, MPH, MBA^2*, Yi-Chien Lee, MS^1* and Roman Casciano, MSc^1*

¹LASER Analytica, New York, NY
²Chimerix Inc., Durham, NC

Aishwarya Ravindran, MBBS^1*, Wilson I. Gonsalves, MD^1*, Shahrukh K. Hashmi, MD¹, Prashant Kapoor, MD¹, Ariela L. Marshall, MD¹, Mustaqeem A. Siddiqui, MD¹ and Ronald S. Go, MD^1,2

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

Adrianne W Casebeer, MPP, MS, PhD^1*, Sari Hopson, MSPH, PhD^1*, Dana A Drzayich Jankus, MS^1*, Zhuliang Tao, MSPH^1*, Stephen Stemkowski, MHA, PhD^1*, Andrew Howe, PharmD, BA^1,2*, Jeffrey Patton, MD^3*, Art Small, MD^4* and Anthony Masaquel, MPH, PhD^4*

¹Comprehensive Health Insights, Humana, Inc., Louisville, KY
²EMD Serono, Inc., Atlanta, GA
³Tennessee Oncology, Nashville, TN
⁴Genentech, Inc., South San Francisco, CA

Stephen Lo^1*, Janet Shu^1*, Margot Phillips^1*, Fangui Sun^2*, John L Berk^1* and Vaishali Sanchorawala¹

¹Boston Medical Center, Boston, MA
²Boston University School of Public Health, Boston, MA

Parshva Patel, MD^1*, Indumathy Varadarajan, MD², Gaurav Varma, MSPH^3*, Trotta Christina, MD^4*, Kristine Ward, MD³, Maneesh Jain, MD³ and Michael Styler, MD⁵

¹Drexel College of Medicine, Drexel University-Hahenmann Hospital, Philadelphia, PA
²Hematology Oncology, Drexel University, Philadelphia, PA
³Drexel University College of Medicine, Philadelphia, PA
⁴Hematology Oncology, drexel University College of Medicine, Philadelphia, PA
⁵Drexel Unviersity College of Medicine, Philadelphia, PA

Jacqueline C. Barrientos, MD¹, Nicole Meyer, MA^2*, Xue Song, PhD^2* and Kanti R Rai, MD³

¹Department of Medicine, Hofstra North Shore-LIJ School of Medicine, Lake Success, NY
²Truven Health Analytics, Cambridge, MA
³North Shore Long Island Jewish Health Systems, New Hyde Park, NY

Mithun Vinod Shah, MD, PhD, C Christopher Hook, MD, Timothy G. Call, MD and Ronald S. Go, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Yeon Joo Lee, MD, MPH^1*, Yao-Ting Hayden Huang, PhD, MPH¹, Seong Jin Kim, MPH^1*, Marina Kerpelev^2*, Victoria Gonzalez^3*, Genovefa A Papanicolaou, MD^1* and Anna Kaltsas^4*

¹Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Information System, Memorial Sloan-Kettering Cancer Center, New York, NY
³Rush University, Chicago, IL
⁴Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Stephen A Schey¹, Casado Montero^2*, Chloe Stengel-Tosetti^3*, Craig Gibson^4* and Sujith Dhanasiri^5*

¹London Bridge Hospital, London, United Kingdom
²Hospital Virgen de la Salud, Toledo, Spain
³Dolon, London, United Kingdom
⁴Celgene Corporation, Summit, NJ
⁵Celgene International, Boudry, Switzerland

Monia Marchetti, MD, PhD^1*, Antonio Cuneo^2*, Francesca Romana Mauro, MD, PhD^3*, Marco Montillo, MD⁴, Elisa Martelli^5* and Maria Paola Pedone^5*

¹Oncology Unit, Ospedale Cardinal Massaia, ASTI, Italy
²Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Ferrara, Italy
³Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
⁴Division of Hematology, Niguarda Ca’ Granda Hospital, Milan, Italy
⁵GILEAD, Milan, Italy

Gregory A. Abel, MD, MPH¹, Tammy T. Hshieh, MD^2*, Nolan B. Condron^1*, Caron A. Jacobson, MD¹, David P. Steensma, MD¹, Jacob P. Laubach, MD¹, Richard M. Stone, MD³ and Jane A. Driver, MD, MPH^2*

¹Dana-Farber Cancer Institute, Boston, MA
²Division of Aging, Brigham and Women's Hospital, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Jesse Keller, MD, Mark A Fiala, BS, CCRP^*, Michael Slade, BA^*, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD, MSCI and Ravi Vij, MD, MBA

Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO

Anureet Copeland, MD^1*, Robert Wehbie, MD, PhD², Monique Clayton^1*, Anderson Black^2*, Barbara Rapchak^3* and Matthew C Foster, MD¹

¹UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
²Rex/UNC Healthcare, Raleigh, NC
³Leap Of Faith Technologies, Crystal Lake, IL

Dorothy Romanus, RPh, MSc, PhD^1*, Mehul Jhaveri, PharmD, PhD^1*, Richard Labotka, MD, MS¹, Henry Henk, PhD^2* and Brian Seal, RPh, MBA, PhD^1*

¹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²HEOR, Optum, Eden Prairie, MN

Areej El-Jawahri, MD¹, Tanya Keenan, MD^2*, Gregory Abel, MD, MPH³, David P. Steensma, MD⁴, Thomas W. LeBlanc, MD, MA⁵, Lara Traeger, PhD^2*, Amir T. Fathi, MD⁶, Daniel J. DeAngelo, MD, PhD⁷, Martha Wadleigh, MD⁴, Gabriela Hobbs, MD^8*, Philip C. Amrein, MD¹, Richard M. Stone, MD⁷, Karen K. Ballen, MD², Yi-Bin Chen, MD² and Jennifer S. Temel, MD^9*

¹Massachusetts General Hospital/Harvard Medical School, Boston, MA
²Massachusetts General Hospital, Boston, MA
³Dana-Farber Cancer Inst., Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Duke Cancer Institute, Durham, NC
⁶Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Massachusetts General Hospital / Dana Farber Harvard Cancer Center, Boston, MA
⁹Hematology-Oncology, Massachusetts General Hospital, Boston, MA

Sundar Jagannath, MD¹, Anuja Roy, PhD^2*, Jonathan K Kish, PhD MPH^3*, Denise Globe, PhD^2*, Orsolya Lunacsek, PhD MBA^4*, Michael T. Eaddy, PharmD, PhD^4*, Emil T Kuriakose, MD², Joanne Willey, RN^5* and David S Siegel, MD, PhD⁶

¹Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Global Health Economics and Outcomes Research, Xcenda, Palm Harbor, FL
⁴Applied Data Analytics, Xcenda, Palm Harbor, FL
⁵Xcenda, Palm Harbor, FL
⁶Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ

Mark A Fiala, BS, CCRP^*, Jesse Keller, MD, Michael Slade, BA^*, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD, MBA and Tanya M Wildes, MD, MSCI

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Annie Guerin, MSc^1*, Saurabh Ray, PhD^2*, Genevieve Gauthier, MSc^1*, Ling-I Hsu, PhD^2*, Maryia Zhdanava^1* and Eric Wu, Ph.D¹

¹Analysis Group, Inc, Boston, MA
²AbbVie, Inc, Chicago, IL

Arun Kumar Arumugam Raajasekar, MBBS^1*, Sindhu Barola, MBBS^2*, Lynne Tehrani, CNS^2* and Abhinav B Chandra, M.D, MSc, FACP³

¹Maimonides Medical Center, Brooklyn, NY
²Maimonides Medical Center, Brooklyn
³Maimonides Cancer Center, Brooklyn, NY

Elizabeth K. O'Donnell, MD^1,2, Jessica Kabrt^1*, Nkiruka Ezenwajiaku^1*, Andrew J. Yee, MD^1,2, Nora Horick^1* and Noopur S. Raje, MD^1,2

¹Massachusetts General Hospital, Boston, MA
²Harvard Medical School, Boston, MA

Gaurav Goyal, MBBS^1*, Lata Nawal, MPH^2*, Kailash Mosalpuria, MD, MPH³ and Peter T. Silberstein, MD⁴

¹Internal Medicine, CHI Health Creighton University Medical Center, Omaha, NE
²Department of Epidemiology, University Of Nebraska Medical Center, Omaha, NE
³Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
⁴Hematology/Oncology, Creighton University Medical Center, Omaha, NE

Rahma Warsame, MD¹, Shaji Kumar, MD¹, Carrie A. Thompson, MD¹, Morie A. Gertz, MD¹, Martha Q. Lacy, MD¹, Francis Buadi, MD¹, Suzanne R. Hayman, MD¹, Nelson Leung, MD^1,2, David Dingli, MD, PhD¹, Yi L. Hwa, NP^1*, John A. Lust, MD, PhD¹, Prashant Kapoor, MD¹, Yi Lin, MD, PhD¹, Ronald S. Go, MD¹, Steven R. Zeldenrust, MD, PhD¹, Robert A. Kyle, MD¹, S. Vincent Rajkumar, MD¹ and Angela Dispenzieri, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Judy Foster, NP^1*, Traci M. Blonquist^2*, Areej El-Jawahri, MD¹, Amir T Fathi, MD¹, Philip C. Amrein, MD¹, Hossein Sadrzadeh, MD³, Andrew M. Brunner, MD⁴, Gabriella Hobbs, MD^1*, Eyal C. Attar, MD⁵, Donna S Neuberg, ScD⁶ and Karen K. Ballen, MD⁵

¹Massachusetts General Hospital/Harvard Medical School, Boston, MA
²Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston
³Capital Health system, Trenton, NJ
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Massachusetts General Hospital, Boston, MA
⁶Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

Xiaomei Ma, PhD^1*, Arlene S. Swern, PhD^2*, Pavel Kiselev, PhD^2*, Albert Fliss, PhD^2*, Jane J. Lu, MS^2*, Bart L. Scott, MD³, David P. Steensma, MD⁴ and Mary M. Sugrue, MD, PhD^2*

¹Yale School of Public Health, New Haven, CT
²Celgene Corporation, Summit, NJ
³Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Dana-Farber Cancer Institute, Boston, MA

Emily S Van Laar, MS^1* and Ola Landgren, MD, PhD²

¹Medscape, New York, NY
²Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Leslie Padrnos, MD¹, Joseph Mikhael, MD², Robert Bennett^3*, Heidi Kosiorek^4*, Amylou Constance Dueck, PhD^5*, Donald W. Northfelt, MD^6*, Raoul Tibes, MD, PhD⁷, Nandita Khera, MD⁸ and Ruben A. Mesa, MD⁹

¹Mayo Clinic Arizona, Scottsdale, AZ
²Division of Hematology, Mayo Clinic, Scottsdale Campus, Scottsdale, AZ
³Arizona State University, Tempe
⁴Mayo Clinic Arizona, Phoenix
⁵Division of Health Sciences Research, Mayo Clinic Arizona, Scottsdale, AZ
⁶Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
⁸Department of Hematology/Oncology, Mayo Clinic Arizona and Phoenix Children's Hospital, Phoenix, AZ
⁹Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Scottsdale, AZ

Subhash Varma, MBBS, MD, Professor & Head, Sub Dean^1*, Uday Yanamandra, MBBS, MD, DNB^2,3*, Alka Khadwal, MD^3*, Gaurav Prakash, MBBS, MD, DM^3*, Vikas Suri, MD^3*, Savita Kumari, MD, DM^3*, Parathan Karunakaran, MD^3*, Shano Naseem, MD^4*, Reena Das, MD^4*, Neelam Varma, MBBS, MD^5* and Pankaj Malhotra, MD, Additional Professor³

¹Department of Internal Medicine (Clinical Hematology Division), Postgraduate Institute of Medical Education & Research, Chandigarh, India
²Department of Internal Medicine, Armed Forces Medical College, Pune, India
³Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, India
⁴Department of Hematology, PGIMER, Chandigarh, India
⁵Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India

Moniba Nazeef, MD¹, Catherine P Leith, MBBChir², Ryan J. Mattison, MD¹, Richard K Yang, MD, PhD^2* and Sanjay Patel, MD, MPH, MSc^2*

¹Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI
²Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

Parth Desai, MD^1*, Julianne Chen^1*, Diane Liu^2*, Jimin Wu^2*, Sairah Ahmed, MD¹, Betul Oran, MD¹, Stefan O. Ciurea, MD¹, Amin M. Alousi, MD¹, Srdan Verstovsek, MD³, Richard E. Champlin, MD¹ and Uday R. Popat, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Lakshmi Radhakrishnan, MPH^1*, Sagar Lonial, MD^2,3 and Ajay K. Nooka, MD, MPH¹

¹Division of BMT, Winship Cancer Institute, Emory University, Atlanta, GA
²Winship Cancer Institute, Emory University, Atlanta, GA
³Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA

Nonglak Kanitsap, MD^1*, Naree Wannissorn, MD.^2*, Arnuparp Lekhakula, MD^3*, Jakrawadee Julamanee, MD^4*, Archrob Khuhapinant, MD, PhD⁵, Chittima Sirijerachai, MD^6*, Kanchana Chansung, MD^6*, Lalita Norasetthada, MD⁷, Weerasak Nawarawong, MD⁸, Suporn Chuncharunee, MD⁹, Pimjai Niparuck, MD^10*, Kitsada Wudhikarn, MD¹¹, Udomsak Bunworasate¹², Tontanai Numbenjapon, MD^13*, Kannadit Prayongratana, MD^13*, Somchai Wongkhantee, MD^14*, Peerapon Wong, MD^15*, Tawatchai Suwanban, MD^16*, Nisa Makruasi, MD^17* and Tanin Intragumtornchai, MD, MSc¹¹

¹Department of Medicine, Thammasat University, Bangkok, Thailand
²Department of Pathology, Thammasart University, Prathum THani, Thailand
³Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand
⁴Department of Internal Medicine, Prince of Songkla University, Songkla, Thailand
⁵Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
⁶Department of Medicine, Khon Kaen University, Khon Kaen, Thailand
⁷Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand
⁸Department of Medicine, Chiang Mai University, Chiang Mai, Thailand
⁹Ramathibodi Hospital, Bangkok, Thailand
¹⁰Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
¹¹Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
¹²King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
¹³Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
¹⁴Department of Internal Medicine, Khonkaen Regional Hospital, Khon Kaen, Thailand
¹⁵Department of Medicine, Naresuan University, Phitsanulok, Thailand
¹⁶Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
¹⁷Department of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand

Jason Valent, MD¹, Christy Samaras, DO¹, Debbie Hastings^1*, Beth M Faiman, PhD, RN, MSN, CNP, AOCN¹, Kimberly Hamilton, CNP^2*, Brian J. Bolwell, MD³, Janice Reed, RN^2*, Mary Ann Karam, RN^1*, Chad Cummings, MBA^1*, Katherine Tullio, MPH, MS^1*, Mitchell R. Smith, MD, PhD³, Hien K. Liu, MD³ and Frederic J Reu¹

¹Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
²Cleveland Clinic, Taussig Cancer Institute, Cleveland
³Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH